Where Edwards Lifesciences Stands With Analysts
Portfolio Pulse from Benzinga Insights
Edwards Lifesciences (NYSE:EW) has received positive analyst ratings in the last quarter, with 13 bullish and 8 somewhat bullish ratings. The company has an average 12-month price target of $101.46, which has increased by 1.32% over the past month.
August 04, 2023 | 9:20 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Edwards Lifesciences has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up in the short term.
Analyst ratings often influence investor sentiment. The positive ratings for Edwards Lifesciences indicate a bullish outlook, which could lead to increased demand for the stock and potentially drive up the price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100